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Abstract
The NAD-dependent deacetylase Sir2 was initially identified as a mediator of replicative lifespan
in budding yeast and was subsequently shown to modulate longevity in worms and flies1,2. Its
mammalian homologue, SIRT1, appears to have evolved complex systemic roles in cardiac
function, DNA repair, and genomic stability. Recent studies suggest a functional relevance of
SIRT1 in normal brain physiology and neurological disorders. However, it is unknown if SIRT1
plays a role in higher-order brain functions. We report that SIRT1 modulates synaptic plasticity
and memory formation via a microRNA-mediated mechanism. Activation of SIRT1 enhances,
while its loss-of-function impairs, synaptic plasticity. Surprisingly, these effects were mediated via
post-transcriptional regulation of CREB expression by a brain-specific microRNA, miR-134.
SIRT1 normally functions to limit expression of miR-134 via a repressor complex containing the
transcription factor YY1, and unchecked miR-134 expression following SIRT1 deficiency results
in the down-regulated expression of CREB and BDNF, thereby impairing synaptic plasticity.
These findings demonstrate a novel role for SIRT1 in cognition and a previously unknown
microRNA-based mechanism by which SIRT1 regulates these processes. Furthermore, these
results describe a separate branch of SIRT1 signaling, in which SIRT1 has a direct role in
regulating normal brain function in a manner that is disparate from its cell survival functions,
demonstrating its value as a potential therapeutic target for the treatment of CNS disorders.
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The mammalian Sir2 homolog SIRT1 is involved in a variety of complex processes relevant
to aging, including the regulation of oxidative stress, metabolism control, and circadian
rhythms1–4. We previously demonstrated that SIRT1 gain-of-function is neuroprotective in
overactive Cdk5 and mutant SOD models of neurodegeneration, which are relevant to
Alzheimer’s disease and ALS, respectively5. Moreover, SIRT1 has recently been implicated
in molecular pathways regulated by cocaine6, suggesting that, in addition to its involvement
in neurogenesis and neuroprotection, SIRT1 has further functions in the brain that are yet to
be described.
To directly evaluate the physiological role of SIRT1 in learning and memory, mutant mice
lacking SIRT1 catalytic activity in a brain-specific manner (SIRT1Δ) were generated by
crossing mice carrying a floxed SIRT1Δex4 allele7,8 with Nestin-Cre transgenic mice. In
tests of associative memory, SIRT1Δ mice exhibited a significant decrease in freezing
behavior as evaluated by both contextual (Fig. 1a) and tone-dependent (Fig. S2a) fear
conditioning paradigms. Shock sensitivity and locomotor activity did not differ between
SIRT1Δ mice and littermate controls (Figs. 1b, S2b). SIRT1Δ mice showed a similarly
decreased memory performance in a novel object recognition task (Fig. 1c), which relies
upon the hippocampus and cortex9. The time spent exploring the objects during training did
not significantly differ between groups (Fig 1d). In the Morris water maze, SIRT1Δ mice
displayed significantly increased escape latencies in the hidden platform paradigm (Fig. 1e),
while spending less time in the target quadrant in a probe trial (Fig. 1f) compared with
control mice, suggesting that SIRT1 plays a role in spatial learning. Visual function and
swimming ability were not affected in the SIRT1Δ mice (Figs. S2c,d). Together, these
results show that SIRT1 has an important role in several forms of memory.
Next, we used a long-term potentiation (LTP) paradigm to directly determine the role of
SIRT1 in synaptic plasticity. LTP in hippocampal CA1 neurons, induced by two θ burst
(2×TBS) stimulation of the Schaffer collaterals in control mice, was abrogated in SIRT1Δ
mice, demonstrating a requirement of SIRT1 in synaptic plasticity (Fig. 1g). CA1 neurons in
SIRT1Δ mice exhibited normal basal synaptic transmission (Figs. S3a,b) compared to
control mice. These results demonstrate that the LTP deficits caused by SIRT1 inactivation
are not due to impaired synaptic transmission.
The brains of SIRT1Δ mice had a grossly normal anatomy (data not shown). However,
experiments using an antibody against synaptophysin (SVP), which labels the presynaptic
terminals of functional synapses10, revealed significant decreases in SVP immunoreactivity
in the hippocampal striatum radiatum of SIRT1Δ mice, as well as reduced SVP protein
content in the SIRT1Δ hippocampus, compared to controls (Figs. 1h and 1i). Golgi
impregnation demonstrated that the dendritic spine density of CA1 pyramidal neurons is
significantly decreased in the hippocampus of SIRT1Δ mice (Fig. 1j). These results suggest
that SIRT1 regulates synapse formation, synaptic plasticity, and memory formation.
Brain-derived neurotrophic factor (BDNF) and cAMP response binding protein (CREB) are
two genes that play critical roles in synaptic plasticity and modulating synapse formation11–
13
. Both mRNA and protein levels of BDNF were significantly decreased in SIRT1Δ
hippocampi compared with controls (Fig. 2a). CREB binds to several BDNF promoters and
plays a key role in the activity-dependent regulation of BDNF expression14–17. We
performed chromatin immunoprecipitation (ChIP) to further examine the association of
CREB and BDNF promoters. Baseline binding of CREB to BDNF promoters 1, 2, and 4
was reduced in the SIRT1Δ hippocampus (Fig. 2b). As reported previously15,17, binding of
CREB to BDNF promoters 1 and 4, was increased after contextual fear conditioning
training. In SIRT1Δ mice, however, this training-related increase in BDNF promoter 1 and 4
binding by CREB was abolished (Fig. S4a).
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One possible explanation for the decreased CREB binding to BDNF promoters observed in
SIRT1Δ mice is that CREB itself is downregulated. Consistent with this notion, CREB
protein levels were significantly reduced in SIRT1Δ hippocampi (Fig. 2c, left). Although
overall CREB levels were reduced in the SIRT1Δ mice, CREB phosphorylation was still
increased by fear conditioning training (Fig. S4b). However, in contrast to BDNF, mRNA
levels of CREB were not altered (Fig. 2c, right), suggesting that CREB protein levels are
downregulated in SIRT1Δ brains via posttranscriptional mechanisms.
To investigate such mechanisms, we considered a well-known means of posttranscriptional
regulation of gene expression, the inhibition of translation via microRNA (miRNA).
miRNAs are expressed at high levels in the brain18,19, and the involvement of miRNA in
numerous aspects of normal and abnormal brain function has been reported19,20. We
compared the expression of miRNAs in SIRT1Δ hippocampi with littermate control
hippocampi using a miRNA microarray (Exqion Inc), and found that a number of brain-
enriched miRNAs differed in expression between the two groups (Fig. S5). We evaluated
the expression of eight miRNAs that appeared significantly altered in the microarray
analysis, including five upregulated and three downregulated miRNAs, using mature
miRNA-specific quantitative PCR (qPCR). Consistent with the microarray, our qPCR
analyses confirmed significant changes in expression of all eight miRNAs (Fig. 2d).
Of these miRNAs, miRNA-134 was of particular interest, as it is specifically expressed in
the brain and has been demonstrated to negatively regulate dendritic spine formation in
vitro21. Comparative genomic analyses of the 3’UTR of the mouse CREB gene revealed
three partial complementary binding sites for miR-134, with one site being well-conserved
(Fig. S6a). To determine whether miR-134 directly binds to and inhibits the translation of
CREB mRNA, we carried out a CREB activity luciferase reporter assay in which luciferase
is driven by a minimal promoter downstream of CREB-binding elements. Co-transfection of
miR-134 with CRE-Luc resulted in a significant decrease in CREB activity in cultured CAD
cells, a neural cell line (Fig. 2e). As a negative control, we created a miR-134 mutant
containing mutations in the miR-134 seed region (mut-miR-134). Expression of mut-
miR-134 did not affect CREB activity (Fig. 2e). The expression of miR-34b-5p or miR-34c,
two other miRNAs upregulated in brains of SIRT1Δ mice, had no effect on CREB activity
(Fig. S6b), indicating specific regulation of CREB by miR-134. Finally, miR-134 loss-of-
function using a locked-nucleic-acid (LNA)-modified oligonucleotide probe (LNA-
miR-134), which achieves specific knockdown of endogenous miR-134, significantly
enhanced CREB activity (Fig. 2e). These results suggest that miR-134 regulate CREB
protein expression via a post-transcriptional mechanism.
To verify the direct nature of CREB inhibition by miR-134, we generated a luciferase
reporter construct in which the 3’UTR of CREB, containing all three predicted miR-134
target sequences, was inserted downstream of a luciferase expression cassette (WT-CREB).
As expected, co-expression of miR-134 with WT-CREB significantly attenuated reporter
expression (Fig. 2f). A luciferase reporter construct linked to the 3’UTR of CREB
containing multiple mutations within the three miR-134 target sequences (mut-CREB) was
refractory to knockdown by miR-134 (Fig. 2f). Expression of mut-CREB alone resulted in a
significant increase in luciferase activity, indicating a de-repression of the reporter construct
by endogenous miR-134 (Fig. 2f). These results indicate that miR-134 attenuates CREB
expression via a specific interaction with the target regions within the 3’UTR of CREB.
Moreover, overexpression of miR-134, but not mut-miR-134, in cultured CAD cells resulted
in reduced levels of CREB protein relative to a scrambled miR control (Scr-miR; Fig. 2g). In
contrast, delivery of LNA-miR-134 resulted in increased CREB protein levels compared to
LNA-scrambled-miR (LNA-scr-miR) control (Fig. 2g), suggesting that, under normal
conditions, miR-134 has a limiting effect on CREB translation.
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To investigate how SIRT1 modulates miR-134 transcription, we conducted ChIP with an
anti-SIRT1 antibody and examined the association of SIRT1 with DNA sequences spanning
~5 Kb upstream of the Pre-miR-134 sequence. We found that two regions, R3 and R7, could
be specifically amplified from SIRT1 ChIP, suggesting that SIRT1 is associated with
potential regulatory elements upstream of miR-134 (Fig. 3a). The specificity of the
interaction was verified by ChIP analyses from SIRT1 constitutive knockout (KO) mouse
brain tissue8, which yielded a dramatically reduced pull-down of the R3 and R7 fragments
(Fig. 3b). To determine the transcriptional modulating activities of these sites, we cloned R3,
R7, and the control R5 fragment upstream of a minimal promoter in a pCL3-promoter
luciferase reporter construct. Interestingly, co-expression of SIRT1 with reporter constructs
containing either R3 or R7, but not R5, significantly reduced, while SIRT1 shRNA
increased, the expression of the luciferase reporter (Fig. 3c). Collectively, these results
indicate that SIRT1 inhibits miR-134 expression by directly binding to distal inhibitory
elements.
To verify the contribution of miR-134 to the modulation of CREB by SIRT1, we created
SIRT1 loss-of-function in CAD cells by either shRNA-mediated knockdown (shRNA-
SIRT1) or overexpression of a catalytically-inactive mutant of SIRT1 (H363Y)22, both of
which elevated the level of miR-134 in these cells (Fig. 3d). The loss of SIRT1 markedly
inhibited CREB activity, but this effect was reversed by the administration of LNA-miR-134
(Fig. 3e). These results provide strong evidence that SIRT1 loss-of-function attenuates
CREB activity via a miR-134-mediated posttranscriptional mechanism. We searched the R3
and R7 regions for transcription factor consensus binding motifs and discovered Yin Yang 1
(YY1) binding sites within both the R3 and R7 fragments (Fig. 3f, top), but not in any of the
other fragments upstream of the miR-134 coding region. YY1 is a ubiquitous and highly-
conserved transcription factor that can activate or repress gene expression, depending upon
the cellular context23. To determine if YY1 binds to miR-134 regulatory sequences, we
performed ChIP experiments using anti-YY1 and anti-SIRT1 antibodies after both
overexpression and knockdown of YY1 in CAD cells. The anti-YY1 antibody
immunoprecipitated the R3 and R7, but not the R5, fragments, suggesting an association of
YY1 with DNA elements within these fragments (Fig. 3f). The knockdown of YY1 also
reduced YY1 binding to the R3 and R7 miR-134 promoter regions in cultured CAD cells
(Fig. 3f, lower left). Moreover, the binding of SIRT1 to R3 and R7 was impaired after YY1
knockdown (Fig. 3f, lower right), suggesting that SIRT1 cooperates with YY1 in binding to
the upstream regulatory elements of miR-134. Consistent with this idea, in SIRT1
constitutive KO mice, YY1 binding to R3 and R7 of miR-134 was also reduced (Fig. 3g). To
determine the functional consequence of YY1 binding to R3 and R7, we used the pCL3-
promoter luciferase reporter constructs containing R3, R5, or R7 as described in Fig 3c. We
found that YY1 overexpression repressed, whereas YY1 knockdown potentiated, the
luciferase activity driven by R3 and R7 (Fig. 3h). Conversely, YY1 abundance had no
influence on the luciferase activity driven by R5. These results suggest that the binding of
YY1 to R3 and R7 represses transcription. We then investigated the influence of YY1 upon
miR-134 and CREB protein abundance in CAD cells, finding that overexpression of YY1
reduced miR-134 expression, while miR-134 abundance was increased following the
shRNA-mediated knockdown of YY1 (Fig. 3i). Furthermore, CREB levels were positively
regulated by YY1 expression (Fig. 3j). Collectively, these observations support the concept
that SIRT1 is recruited to YY1 DNA binding elements and that the two proteins collaborate
to suppress miR-134 expression.
We next examined the role of miR-134 in synaptic plasticity and memory formation.
miR-134 was overexpressed in area CA1 of the hippocampus via lentiviral-mediated
delivery (Fig. S7a). As observed in SIRT1Δ mice, overexpression of miR-134 abrogated
LTP in CA1 neurons (Fig. 4a), while basal synaptic transmission was not impaired (Fig.
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S7b). miR-134 overexpression in area CA1 also resulted in a significant impairment in long-
term memory formation in the contextual fear-conditioning paradigm (Fig. 4b), but not in
the tone-dependent fear conditioning paradigm (Fig. S7c), a task reliant upon amygdalar
function24. miR-134 overexpression did not affect shock sensitivity (Fig. S7d). Thus,
miR-134 overexpression in the hippocampus closely mimics the effects of SIRT1 loss.
These data demonstrate that the upregulation of miR-134 plays a role in the synaptic
plasticity impairment observed in SIRT1Δ mice.
To assess, in vivo, whether miR-134 upregulation underlies the impairment of LTP observed
in SIRT1Δ mice, we examined the effect of miR-134 knockdown using injections of the
LNA-miR-134 probe into hippocampal CA1 region (Figs. S8a,b). We found that knockdown
of miR-134 restored LTP in acute hippocampal slices from SIRT1Δ hippocampi (Fig. 4c),
whereas the LNA probe containing a scrambled sequence (LNA-scr-miR) failed to
ameliorate the LTP defects in SIRT1Δ mice. Moreover, injections of LNA-miR-134, but not
LNA-scr-miR, into SIRT1Δ mouse hippocampus markedly rescued contextual (Fig. 4d), but
not tone-dependent (Fig. S8c), fear memory formation. All groups exhibited normal shock
sensitivity (Fig. S8d). Examination of hippocampal lysates harvested from control and
SIRT1Δ mice injected with LNA-scr-miR revealed that both CREB and BDNF protein
levels were reduced in SIRT1Δ mice (Fig 4e). However, LNA-miR-134 treatment restored
CREB and BDNF protein to levels comparable to control mice (Fig. 4e).
Our data indicate that the impairments in memory and synaptic plasticity observed in
SIRT1Δ mice are, at least, partly mediated via an up-regulation of miR-134 and consequent
translational inhibition of miR-134 target genes. SIRT1 normally functions in cooperation
with YY1, and potentially additional proteins, to restrict the expression of miR-134 and that,
upon SIRT1 loss-of-function, higher levels of miR-134 negatively regulate synaptic
plasticity via the translational block of key plasticity proteins such as CREB (Fig. S1),
which subsequently mediates the various synaptic plasticity impairments observed following
SIRT1 loss-of-function.
We previously demonstrated that SIRT1 promotes neuronal survival in age-dependent
neurodegenerative disorders5. We have now found that SIRT1 activity also promotes
plasticity and memory in a direct manner through a mechanism distinct from its established
neuroprotective activity. This result demonstrates a multi-faceted role of SIRT1 in the brain,
further highlighting its potential as a target for the treatment of neurodegeneration and
conditions with impaired cognition, with implications for a wider range of CNS disorders.
Methods Summary
For detailed methods, please see the supplemental materials. The SIRT1 KO and
SIRT1Δex4/Nestin-Cre mice were provided by the laboratory of Leonard Guarente. The
plasmids and LNA-miRNA (Ambion) were transfected into mouse CAD cells using
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. RNA
extraction, purification, and quantitative PCR were performed according to the
manufacturer's protocols. Tissue and cell lysis, protein concentrations, and western blot
analyses were prepared as described previously5. Immunoblot data were quantified by
measuring the band intensity with NIH imaging software and UN-SCAN-it gel digitizing
software (Silk Scientific). Immunostaining was performed as described previously3 with
LSMeta10 software and a confocal microscope (Zeiss). All behavioral testing was
performed as described previously5 and elsewhere. The data were analyzed by unpaired
Student’s t-test. Two-way ANOVA was used to compare differences between groups at
several time points.
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Figure 1. SIRT1 loss-of-function impairs memory and synaptic plasticity
(a) Freezing time of SIRT1Δ mice and littermate controls (Cont) 24 hr after contextual fear
conditioning training. (b) Shock sensitivities did not differ between control and SIRT1Δ
mice. (c) SIRT1Δand control mice were tested for novel object discrimination 24 hrs after
training. (d) Pre-test exploration times were equal for each object. (e) Escape latencies of
SIRT1Δ and control mice were examined with the Morris water maze hidden platform test.
(f) Left panel: the swimming time spent in each quadrant in the probe trial on day 5 (T,
target; L, left; O, opposite; R, right). Right panel: representative path tracings of the probe
test. (g) LTP measurements were performed in the CA1 region of acute slices from SIRT1Δ
mice and controls. (h) SVP immunoreactivity in SIRT1Δ and control hippocampi. (i)
Western blots from hippocampal lysates examined SVP in SIRT1Δ and control mice. (j)
The density of Golgi-impregnated hippocampal neuronal dendritic spines was measured in
SIRT1Δ and control mice. Scale bar: 10 μm. TBS: theta-burst stimulation, SVP:
synaptophysin, OD: optical density. *p < 0.05, **p < 0.01, ***p < 0.001. All histograms
represent average ± SEM.
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Figure 2. BDNF and CREB are downregulated, while miRNA-134 is up-regulated, in SIRT1Δ
mice
(a) BDNF in the SIRT1Δ and control mouse hippocampus. Left: mRNA levels. Right:
Western blot. (b) Chromatin immunoprecipitation (ChIP) with an anti-CREB antibody was
followed by qPCR for BDNF promoters 1, 2, and 4. (c) CREB in the SIRT1Δ and control
mouse hippocampus. Left: Western blot. Right: mRNA levels. (d) qPCR of selected
miRNAs from hippocampi of SIRT1Δ and control mice. (e) CAD cells were transfected
with the plasmids or LNA indicated together with CRE-Luc. (f) Luciferase reporter
constructs containing either a wildtype (WT-CREB) or a mutated (mut-CREB) CREB
3’UTR region, were cotransfected with miR-134 or control. (g) CREB protein expression in
CAD cells after transfection with the indicated constructs or LNAs. Scr: scrambled, mut:
mutant, LNA: locked-nucleic-acid (LNA), CRE-Luc: CREB activity reporter construct. **p
< 0.01; ***p < 0.001; NS, not significant.
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Figure 3. SIRT1 regulates CREB through miR-134
(a) From SIRT1 ChIP, two genomic regions, R3 and R7, corresponding to base pairs
1418~830 and 3427~2901 upstream of miR-134, respectively, were amplified from the wild
type, but not the SIRT1 total knockout (SIRT1KO), brain tissue. (b) miR-134 promoter
regions R3 and R7 were quantified from SIRT1 ChIP with qPCR. (c) Reporter constructs
containing R3, R5, or R7 regions upstream of a minimal promoter in a luciferase reporter
were co-transfected with SIRT1, SIRT1 shRNA, or empty vector. (d) qPCR for miR-134 in
CAD cells after transfection with the indicated plasmids. (e) CRE-luciferase reporter assay
in CAD cells. (f) ChIP was performed from CAD cells with anti-YY1 and anti-SIRT1
antibodies. (g) Anti-YY1 ChIP followed by qPCR for regions R3 and R7. (h) Luciferase
reporter constructs containing R3, R5, or R7 regions were co-transfected with the indicated
plasmids. (i) miR-134 levels were measured in CAD cells with qPCR after transfection with
the indicated plasmids. (j) Western blotting measured CREB protein levels in CAD cells
after transfections with the indicated plasmids. shRNA Cont: scrambled shRNA control. *p
< 0.05; **p < 0.01; ***p < 0.001; NS: not significant. All histograms represent average ±
SEM.
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Figure 4. MiR-134 knockdown rescues the LTP and memory impairments caused by SIRT1
deficiency
(a) LTP was measured in acute hippocampal slices of mice six weeks after injection with
Lv-miR-134 or Lv-Scr-miR. (b) Lv-miR-134 and Lv-Scr-miR-injected mice were tested
with a contextual fear conditioning task. (c) Following hippocampal injections with LNA-
miR-134 or LNA-scr-miR, LTP was measured in SIRT1Δ and control mouse acute
hippocampal slices. (d) Freezing behavior in the contextual fear conditioning task was
examined in SIRT1Δ and control mice after hippocampal injections of LNA-miR-134 or
LNA-scr-miR. (e). Western blot for CREB and BDNF in brain lysate after in vivo miR-134
knockdown. Control scrambled miR lentivirus: Lv-Scr-miR. **p < 0.01, NS: not significant.
Gao et al. Page 11
Nature. Author manuscript; available in PMC 2011 February 1.
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
H
H
M
I Author M
anuscript
